Answers are grounded in this paper and cite their sources.
Patients with primary refractory or relapsed-acute myeloid leukemia (RR-AML), particularly older adults, have dismal outcomes and limited therapy options [1]. Given the tolerability of hypomethylat...
No takes yet. Share an insight, caveat, or question.
Stahl et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: